Table 3.
Adverse Events Reported by >5% of Subjects Treated With G-Pump Glucagon.
| Description | G-Pump glucagon |
GlucaGen glucagon |
||
|---|---|---|---|---|
| Subj (%) | Event | Subj (%) | Event | |
| Total number of subjects | 19 | 19 | ||
| Number of subjects who had at least 1 AE | 16 (84.2%) | 12 (63.2%) | ||
| Number of all events | 41 | 21 | ||
| Well-defined erythema | 9 (47.4%) | 14 | 2 (10.5%) | 2 |
| Nausea | 5 (26.3%) | 6 | 6 (31.6%) | 6 |
| Well-defined edema | 5 (26.3%) | 7 | 1 (5.3%) | 1 |
| Dizziness | 2 (10.5%) | 3 | 0 (0.0%) | 0 |
| Headache | 2 (10.5%) | 3 | 5 (26.3%) | 5 |
| Vomiting | 2 (10.5%) | 4 | 3 (15.8%) | 3 |